303 related articles for article (PubMed ID: 30232913)
1. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
Perksanusak T; Panyakhamlerd K; Hirankarn N; Suwan A; Vasuratna A; Taechakraichana N
Climacteric; 2018 Dec; 21(6):581-585. PubMed ID: 30232913
[TBL] [Abstract][Full Text] [Related]
2. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
3. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
4. Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis.
Anastasilakis AD; Makras P; Pikilidou M; Tournis S; Makris K; Bisbinas I; Tsave O; Yovos JG; Yavropoulou MP
J Clin Endocrinol Metab; 2018 Mar; 103(3):1206-1213. PubMed ID: 29309589
[TBL] [Abstract][Full Text] [Related]
5. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
6. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
[TBL] [Abstract][Full Text] [Related]
7. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
8. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
[TBL] [Abstract][Full Text] [Related]
9. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
Furman K; Gut P; Sowińska A; Ruchała M; Fichna M
Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
[TBL] [Abstract][Full Text] [Related]
10. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
[TBL] [Abstract][Full Text] [Related]
11. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
[TBL] [Abstract][Full Text] [Related]
12. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
13. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
[TBL] [Abstract][Full Text] [Related]
14. The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women.
Kučukalić-Selimović E; Valjevac A; Hadžović-Džuvo A
Bosn J Basic Med Sci; 2013 Nov; 13(4):259-65. PubMed ID: 24289763
[TBL] [Abstract][Full Text] [Related]
15. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
Ageev FT; Barinova IV; Seredenina EM; Orlova IaA; Kuz'mina AE; Masenko VP; Kochetov AG
Kardiologiia; 2013; 53(6):51-8. PubMed ID: 23953046
[TBL] [Abstract][Full Text] [Related]
16. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
17. Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.
Hansen KE; Nieves JW; Nudurupati S; Metz DC; Perez MC
Gastroenterology; 2019 Mar; 156(4):926-934.e6. PubMed ID: 30445008
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women.
Wei X; Zhang Y; Xiang X; Sun M; Sun K; Han T; Qi B; Xie Y; Zhang R; Zhu L
Dis Markers; 2021; 2021():6690095. PubMed ID: 33968284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
